Patriot Financial Group Insurance Agency, LLC Medicenna Therapeutics Corp. Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$0.28 - $0.51 $448 - $816	-1,600 Reduced 9.64%	15,000 $4,000
Q2 2023 Jul 17, 2023	SELL	$0.44 - $0.82 $1,232 - $2,296	-2,800 Reduced 14.43%	16,600 $7,000
Q3 2022 Oct 31, 2022	BUY	$0.83 - $1.78 $1,245 - $2,670	1,500 Added 8.38%	19,400 $16,000
Q4 2021 Jan 10, 2022	SELL	$1.53 - $2.85 $7,650 - $14,250	-5,000 Reduced 21.83%	17,900 $29,000
Q2 2021 Jul 30, 2021	BUY	$2.97 - $4.28 $6,979 - $10,058	2,350 Added 11.44%	22,900 $69,000
Q4 2020 Jan 15, 2021	BUY	$3.7 - $5.97 $8,140 - $13,134	2,200 Added 11.99%	20,550 $96,000
Q3 2020 Oct 21, 2020	BUY	$3.55 - $4.67 $65,142 - $85,694	18,350 New	18,350 $76,000

Others Institutions Holding MDNA

# of Institutions

Shares Held

863K

Call Options Held

Put Options Held

View Full List

About Medicenna Therapeutics Corp.

Ticker MDNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,637,504
Market Cap $21.6M
Description
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as...

More about MDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account